Oncology
Team SDR
Synthetic Lethality in DNA Repair
The group aims to translate new synthetic lethal interactions between DNA repair genes into novel therapeutic targets in oncology. By performing targeted pooled screens in cells deficient in DNA repair genes, team SDR will strive to identify and characterize new drug targets in DNA repair and DNA replication as a potent tool to increase the efficiency of clinically used DNA damaging agents.
Mentors
- Dr. Balca Mardin (Industry Mentor)
Head of Laboratory, DNA Damage Response Research at Merck - Dr. Amir Abdollahi (Academic Mentor)
Translational Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg
